| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1Departamento de Fisiología, Biofísica y Neurociencias, Centro de Investigación y Estudios Avanzados; 2Departamento de Biofísica, Instituto de Fisiología Celular; and 3Neurociencias, Facultad de Estudios Superiores-Iztacala, Universidad Nacional Autónoma de México, Federal District, Mexico City, Mexico
Submitted 26 June 2006; accepted in final form 3 August 2006
 |
ABSTRACT |
|---|
|
|
|
INTRODUCTION |
|---|
|
; Turner et al. 1998) through its projections to the subthalamic nucleus (STN) and to other basal ganglia structures that are inhibited by GABAergic synaptic inputs (Beckstead 1983; Gandia et al. 1993; Kita and Kita 2001; Kita and Kitai 1991, 1994; Parent et al. 2000; Sato et al. 2000a; Shinonaga et al. 1992; Windels et al. 2005).
In turn, GP neurons receive and integrate several entries. Their main inhibitory afferents come from the striatum (Cooper and Stanford 2001; Engler et al. 2006; Fonnum et al. 1978; Gimenez-Amaya and Graybiel 1990; Hazrati and Parent 1992; Kawaguchi et al. 1990; Pan and Walters 1988; Parent et al. 1984; Shin et al. 2003; Tremblay and Filion 1989) and from axon collaterals that interconnect GP neurons themselves (Kita et al. 2004; Parent et al. 2000; Shin et al. 2003), although their main excitatory inputs come from the STN (Hazrati and Parent 1992; Kita and Kitai 1991; Nambu et al. 2000; Sato et al. 2000b; Smith et al. 1990) and from thalamic intralaminar nuclei (Mouroux et al. 1997; Yasukawa et al. 2004). Connections between STN and GP form the principal site of reciprocally innervated excitatory and inhibitory neurons in the basal ganglia (Bevan et al. 2002b). When inhibitory and excitatory neuronal populations are reciprocally innervated, they could form the basis of a central pattern generator (Grillner 2003; Terman et al. 2002; Yuste et al. 2005) that may transform excitatory drives into spatiotemporal patterns of oscillatory activity for the generation of motor programs (Bevan et al. 2002b; Plenz and Kitai 1999).
The above-mentioned afferents converging onto pallidal neurons follow a structured topographical arrangement: the GP network (Hazrati and Parent 1992; Kaneda et al. 2002; Shink et al. 1996; Yasukawa et al. 2004). These inputs are integrated by pallidal neurons with the important contribution of a distinct dopaminergic innervation from neurons of the subtantia nigra pars compacta (Debeir et al. 2005; Gauthier et al. 1999; Lindvall and Bjorklund 1979; Prensa and Parent 2001; Ruskin and Marshall 1997). The way in which dopaminergic innervation modulates the GP network is a matter of study (e.g., Costall and Naylor 1972; Galvan et al. 2001; Hauber and Lutz 1999; Kreiss et al. 1997; Nakanishi et al. 1985; Querejeta et al. 2001). For example, a presynaptic modulation of the striatopallidal projection through D2-class receptors (Cooper and Stanford 2001; Floran et al. 1997) was previously described. In addition, a postsynaptic modulation of inhibitory inputs through D4-receptor activation (Ariano et al. 1997; Mauger et al. 1998; Mrzljak et al. 1996; Shin et al. 2003) was also proposed.
Because it was recently shown that subthalamic projections to subtantia nigra pars reticulata are presynaptically modulated by dopamine (Ibañez-Sandoval et al. 2006), this work investigated the possibility that the subthalamopallidal connections were also modulated by dopamine. Correspondingly, it is shown here that D2/3 and D4 receptor activation modulates the subthalamopallidal input onto GP neurons. A preliminary report of these results was previously presented in abstract form (Hernandez et al. 2004).
|
|
METHODS |
|---|
|
All procedures were carried out in accordance with the National Institutes of Health Guide for Care and Use of Laboratory Animals and were approved by the Institutional Animal Care Committees of the CINVESTAV and UNAM. The experiments were performed on brain slices obtained from Wistar rats [postnatal day (PD) 14 to PD 21]. The rats were anesthetized and decapitated. The brain was rapidly immersed for 1 min in cold oxygenated saline (about 4°C; 95% O2-5% CO2) of the following composition (in mM): 124 NaCl, 2.5 KCl, 1.3 MgCl2, 1.2 NaH2PO4, 2.4 CaCl2, and 10 glucose. The same saline but with choline chloride (124 mM) instead of NaCl was used during the slicing procedure. Parasagittal slices (300 µm) containing both GP and STN (see Fig. 1) were cut on a vibroslicer (Lancer, Technical Products International, St. Louis, MO) and transferred to the saline with NaCl (above). The slices were left for equilibration for at least 1 h in oxygenated saline at room temperature (about 25°C). After equilibration, a single slice was transferred to a recording chamber placed on the stage of an upright microscope and was continuously superfused (2–3 ml min–1) with oxygenated saline at room temperature.
|
Recordings were made at room temperature (about 25°C) from neurons located inside the GP boundaries as seen in the parasagittal slice (Fig. 1). Neurons were visualized using infrared differential interference videomicrosocopy with a x40 water-immersion objective (Hamamatsu C2400-50, Hamamatsu Photonics Systems USA and Axioscop, Carl Zeiss, Oberkochen, Germany.). Micropipettes for whole cell recordings were pulled (Sutter Instrument, Novato, CA) from borosilicate glass tubes (1.5 mm outer diameter, WPI, Sarasota, FL) for a final resistance of 2–5 M
when filled with internal saline of the following composition (in mM): 120 KSO3CH3, 16 KCl, 2 MgCl2, 10 HEPES, 1.1 K2-EGTA, 1.1 ATP-Mg, 1.1 GTP-Na, and 5 mM QX-314 (pH 7.3 adjusted with KOH and 287–290 mOsm L–1). QX-314 was used to avoid contamination of synaptic responses by unclamped action currents. Voltage-clamp recordings were made with an Axopatch 200A amplifier (Axon Instruments, Foster City, CA). Liquid junction potentials (
5 mV) were not corrected.
Recordings were acquired at 10 kHz using a Digidata 1200 interface (Axon), Bessel filtered at 5 kHz, and analyzed with pCLAMP (v 7.0) (Axon). Access resistance (7–20 M) was monitored continuously and experiments were abandoned if changes >20% occurred.
Histochemistry
As described elsewhere (see Ibañez-Sandoval et al. 2006; Vergara et al. 2003), a sharp micropipette (tip <0.5 µm) filled with external saline and 5% biocytin (Sigma-Aldrich, St. Louis, MO) was placed inside the STN borders (near the middle) and left there for 1 h while the slice was constantly superfused. Thereafter the pipette was retired and the slice was superfused with oxygenated saline for another 6 h. The slice was then fixed overnight in 0.1 M phosphate-buffered saline (PBS; pH = 7.4; 4°C) with 4% paraformaldehyde and 1% picric acid. Afterward, slices were infiltrated with 30% sucrose and cut on a vibratome (Ted Pella, Reading, CA) into 60-µm sections. After washing with Tris-buffered saline (TBS) containing Triton X-100 and avidin–biotin–peroxidase complex (1:100; Vector Laboratories, Burlingame, CA) for 4 h at room temperature, the slices were reacted with 3,3'-diaminobenzidine tetrahydrochloride (DAB; 0.05%) and H2O2 (0.003%) in TBS and mounted on slides to visualize the bound horseradish peroxidase (HRP). This enabled resolution, through transillumination microscopy, of labeled neurons inside the STN (Fig. 1C) (Leica Imaging Systems, Cambridge, UK) and, most important, of abundant subthalamopallidal fibers projecting to their target (Fig. 1, D and E) (Hazrati and Parent 1992; Sato et al. 2000b; Smith et al. 1990).
Evoked synaptic currents
Synaptic currents were evoked in GP neurons by field stimulation with concentric bipolar tungsten electrodes (50 µm at the tip, 1 k DC resistance; FHC, Bowdoinham, ME). The stimulating electrode was placed either on the STN itself or on the internal capsule approaching the caudoventral part of the GP (Ogura and Kita 2000), where subthalamopallidal projections were seen to run in histochemistry experiments (see Fig. 1D). The likelihood of attaining an excitatory connection was one out of 10 cases when field stimulation was in the STN itself. The probability increased to at least eight out of 10 cases when field stimulation was in the internal capsule, but decreased to zero when the stimulus was located a few microns outside this path (Fig. 1, C and D) (Hanson and Jaeger 2002). The frequency of stimulation was 0.1 Hz and the strength of the pulses was adjusted to obtain roughly 70% of the maximal excitatory postsynaptic current (EPSC) amplitude. The location of dopamine receptors involved in the modulation of the subthalamopallidal transmission was assessed by three different methods: paired-pulse ratio (PPR), frequency and amplitude of spontaneous EPSCs (sEPSCs), and variance–mean analysis (see following text). Glutamatergic EPSCs were isolated by recording the currents in the presence of 30 µM bicuculline to avoid contamination with GABAergic responses (Kita and Kitai 1991; Kita et al. 2005; Nambu et al. 2000). Unless stated otherwise, a point in the time-course graphs is the average of six records, at 0.1 Hz (above), which is one trace per 10 s and one point every minute. However, illustrated records of paired-pulse responses are the average of 25 consecutive events during steady state. sEPSCs were also recorded in the presence of bicuculline (30 µM) and tetrodotoxin (TTX, 1 µM). Traces of sEPSCs were filtered at 2 kHz and digitized at 10 kHz. Time intervals of recorded events during 1.5 min were analyzed (Minianalysis, Jaejin Software, Leonia, NJ) in each experimental condition. The glutamatergic nature of sEPSCs was assessed by their complete elimination by CNQX (30 µM). The N-methyl-D-aspartate (NMDA)–receptor antagonist AP5 (50 µM) was also added in some experiments but no qualitative difference was found at this holding potential (–80 mV) with experiments that used only CNQX (cf. Ibañez-Sandoval et al. 2006).
When the paired-pulse protocol was performed with field stimulation, interpulse intervals of about 50 ms were used. Changes in the paired-pulse ratio (PPR) of EPSC responses (PPR = second EPSC/first EPSC) are known to be linearly proportional to the probability of release and the paired-pulse protocol was demonstrated to detect presynaptic actions of transmitters (e.g., Baldelli et al. 2005; Bolshakov and Siegelbaum 1995; Dunwiddie and Hass 1985; Guzman et al. 2003; Ibañez-Sandoval et al. 2006; Kamiya and Zucker 1994; Salgado et al. 2005; Zucker 1999). Nonstationary fluctuations analysis was performed from 60 consecutive 50-Hz trains evoked at 0.1 Hz to perform variance–mean analyses in which mean amplitudes of evoked EPSCs (corrected for basal lines from previous EPSCs) were plotted against their peak variance: variance–mean (V–M) plots (Clements and Silver 2000; Ibañez-Sandoval et al. 2006; Koos et al. 2004; Salgado et al. 2005). Then, a parabola of the form
 | (1) |
Fig. 9). where y represents evoked EPSC peak variance (ordinates), x represents EPSC mean peak amplitude (abscissae), and A and B are free parameters. Basically, parameter A indicates the initial slope of the parabola and parameter B depends on the width of the parabola. From this fit, a weighted average of the quantal amplitude (Qw) was obtained
 | (2) |
 | (3) |
 | (4) |
|
|
|
|
|
|
|
|
All data are given as means ± SE unless stated otherwise. Significance of the effect of drugs as well as the significance of the differences in paired-pulse ratios was tested with nonparametric statistics: the Wilcoxon t-test or Mann–Whitney's U test, depending on paired or unpaired samples. When the same sample had more than one treatment Friedman's statistics with post hoc Student–Newman–Keuls test was used. Statistical differences of fitted functions were assessed by comparing the obtained parameters and their estimation errors with Student's t-test.
Effects on sEPSCs were estimated by Kolmogorov–Smirnov two-sample test from cumulative distribution amplitudes or cumulative distributions of interevent intervals (Minianalysis).
Drugs
Drugs were stored in the freezer as dry aliquots and stock solutions were prepared just before each experiment and added to the perfusion solution in the final concentration. Bicuculline methiodide, 3,4-dihydroxyphenethylamine (dopamine), trans-(–)-4aR-4,4a,5,6,7,8,8a,9-octahydro-5-propyl-1H-pyrazolo(3,4-g)quinoline (quinpirole), S-(–)-5-amino-sulfonyl-N-[(1-ethyl-2-pyrrolidinyl)-methyl]-2-methoxybenzamide (sulpiride), 6-cyano-7-nitroquinoxalline-2,3-dione (CNQX), D-(–)-2-amino-5-phosphonopentanoic acid (AP5), N-[[4-(2-cyanophenyl)-1-piperazinyl]methyl]-3-methyl-benzamide maleate (PD 168,077), (3-[(4-[4-chlorophenyl]piperazin-1-yl)methyl]-1H-pyrrolo[2,3-b]pyridine) hydrochloride (L-745,870), lidocaine N-ethyl bromide (QX-314), and tetrodotoxin (TTX) were obtained from Sigma (St. Louis, MO). Drugs were diluted into the bath solution.
|
|
RESULTS |
|---|
|
All recordings were made from neurons situated inside the GP borders, during field stimulation of the subthalamopallidal path (see METHODS). It is known that there are different populations of neurons in the GP (Cooper and Stanford 2000; Kita and Kitai 1994; Nambu and Llinas 1997). They can express GAD, calbindin, parvalbumin, or enkephalin (Hoover and Marshall 1999; Kita and Kita 2001; Rajakumar et al. 1994; Voorn et al. 1999). Field stimulation inside the STN borders or in the internal capsule (see METHODS) could evoke antidromic action potentials in some GP neurons, sometimes without evoking an excitatory postsynaptic potential (EPSP) with an orthodromic action potential (Fig. 1A, top; stimulus artifact is signaled with an arrowhead). This antidromic action potential could collide with an action potential evoked with a depolarizing current injection [Fig. 1A, bottom; artifact of antidromic stimulation (arrowhead) can be seen inside the refractory period of the direct spike; note the absence of synaptic response or autorregenerative spike] (Kita and Kitai 1991). On the other hand, field stimulation inside the GP borders could evoke antidromic action potentials in some STN neurons, sometimes without evoking an inhibitory postsynaptic potential (IPSP) (Fig. 1B, top; stimulus artifact is signaled with an arrowhead). This antidromic action potential could collide with an action potential evoked with a depolarizing current injected on a STN neuron (Fig. 1B, bottom; arrowhead signals the artifact of antidromic stimulation). Staining after anterograde transport of biocytin injected inside the STN borders (Fig. 1C; see labeled STN neurons around the site of injection) (see Ibañez-Sandoval et al. 2006) can disclose subthalamopallidal fibers in a parasagittal brain slice that includes both STN and GP (Fig. 1D). Axons emerging from STN neurons had a varicose appearance and could be followed entering the internal capsule toward the GP with other labeled fibers (Fig. 1E; white arrows). In some cases, retrogradely labeled GP neurons could also be observed (Fig. 1F), with morphology similar to that described previously (Kita and Kita 2001; Kita and Kitai 1994; Ogura and Kita 2000), i.e.: variable (oval or triangular) shape with three to five primary dendrites. Thus abundant anterograde labeling and some retrograde labeling, together with antidromic activation in either way, suggested that some reciprocal connections between the GP and STN are preserved in a parasagittal brain slice of the present characteristics (see METHODS) (Ogura and Kita 2000). Taken together, these results (n = 6 slices) suggested that field stimulation in the present conditions is mostly the product of the orthodromic activation of the subthalamopallidal pathway in vitro (see also Hanson and Jaeger 2002).
Glutamatergic synaptic responses recorded in GP neurons after stimulation of the subthalamopallidal pathway
The electrophysiological properties of GP neurons were thoroughly characterized in previous studies (e.g., Chan et al. 2004; Cooper and Stanford 2000; Kita and Kitai 1991; Nambu and Llinas 1994; Overton and Greenfield 1995). During the present work, neurons of previously described classes were recorded. For example, voltage records of a representative neuron (without QX-314) that responded to subthalamopallidal stimulation are depicted in Fig. 2A. As in the case of this neuron (Fig. 2A), many neurons recorded inside the GP borders exhibited a characteristic slowly developing voltage- and time-dependent rectification when injected with hyperpolarizing current pulses fired spontaneously, could fire at high frequencies, and showed a rebound firing after hyperpolarizing pulses (Chan et al. 2004; Cooper and Stanford 2000; Nambu and Llinas 1994). However, QX-314 was used in most cases to avoid contamination of the synaptic response with orthodromic unclamped active currents (see METHODS) (Kita and Kitai 1991; Kita et al. 2005; Nambu et al. 2000). Therefore in most cases, we did not characterize, electrophysiologically, the type of postsynaptic neuron recorded. Second, the criterion to accept an experiment was the synaptic response to subthalamopallidal pathway stimulation (see above). For these reasons, our sample could be biased toward some neuronal classes, i.e., those that preferentially receive STN inputs (Hoover and Marshall 1999; Kita and Kita 2001; Rajakumar 1994). The dopaminergic modulation of the synaptic responses described below did not appear to differ from one experiment to the other once the connection was stable.
Synaptic currents onto another neuron (in the presence of QX-314; see METHODS), evoked by stimulating the subthalamopallidal pathway, are illustrated in the inset of Fig. 2B. These currents were recorded at different holding potentials in the presence of bicuculline (30 µM) and AP5 (50 µM). The current–voltage relationship (I–V plot) for the peak EPSC amplitude had a linear relationship with a reversal potential around 0 mV (Fig. 2B). This I–V plot is typical of synaptic currents flowing through 
-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate receptor channels (e.g., Jonas et al. 1993). In fact, most EPSC was carried by AMPA/kainate receptors in these conditions as confirmed by CNQX (10 µM) blockage (Fig. 2C), which practically abolished most of the synaptic current when evoked at a holding potential of –80 mV. Subsequent addition of AP5 (50 µM), a selective blocker of NMDA receptor channels, eliminated a minimal residual current (Fig. 2C, circles) (cf. Ibañez-Sandoval et al. 2006). The actions of both blockers were reversible (Fig. 2C). When no blockers were added, currents were seen to remain stable for 
30 min with these stimulation parameters (Fig. 2C, triangles). In the present conditions, an EPSC of these characteristics is expected, given the previous information about the subthalamopallidal connection (see Kita and Kitai 1991; Kita et al. 2005; Nambu et al. 2000).
Dopaminergic modulation of subthalamopallidal excitation
Dopamine (10 µM) reversibly reduced peak EPSC amplitude by 34%, from 62 ± 9 pA in the control to 42 ± 8 pA after dopamine (Fig. 3A and histogram in Fig. 3B; n = 7; P < 0.0002; Wilcoxon's t-test); representative records at the bottom are numbered according to the illustrated time course. To determine the type of receptor involved in the action of dopamine, the slices were exposed to dopamine in the presence of sulpiride, a selective D2/3 receptor antagonist, and then, to dopamine alone, after washing sulpiride off. As shown in the time course depicted in Fig. 3C, sulpiride could not block all dopamine action. A sulpiride-resistant reduction of the EPSC by dopamine was evident. Dopamine significantly reduced EPSCs by 29% in the presence of sulpiride: from 96 ± 9 pA in the control to 68 ± 6 pA in the presence of dopamine plus sulpiride (n = 7; P < 0.001; Friedman's nonparametric ANOVA with pairwise comparisons using Student–Newman–Keuls test). Figure 3, C and D also shows that when sulpiride was washed off, an additional sulpiride-sensitive reduction was revealed. EPSC reduction was enhanced from 29 to 41%, down to 56 ± 6 pA (Fig. 3D; n = 7; P < 0.001; Friedman's nonparametric ANOVA with pairwise comparisons using Student–Newman–Keuls test). In summary, the results showed that dopamine can modulate the subthalamopallidal EPSC by reducing it and that this reduction has sulpiride-resistant and sulpiride-sensitive components, that is, D2/3 receptors are only partially responsible for the dopaminergic modulation.
To be sure that D2/3 receptors are not the only ones involved in this action, we studied the effects of quinpirole (1 µM), a potent dopaminergic receptor agonist that activates all three receptors of the D2-class (D2-, D3-, and D4-type receptors), also in the presence and absence of sulpiride (1 µM). The time course in Fig. 4A shows that quinpirole also has an effect in the presence of sulpiride (Fig. 4A) The sulpiride-resistant action was a 17% reduction of the EPSC, from 104 ± 8 pA in the control to 86 ± 7 pA in the presence of both quinpirole and sulpiride (Fig. 4, A and B; n = 11; P < 0.01; Friedman's nonparametric ANOVA with pairwise comparisons using Student–Newman–Keuls test). After sulpiride removal, a sulpiride-sensitive reduction of EPSC (from 17 to 39%) by quinpirole was also revealed, down to 63 ± 4 pA (Fig. 4, A and B; n = 11; P < 0.01; Friedman's nonparametric ANOVA with pairwise comparisons using Student–Newman–Keuls test). The locus of quinpirole actions was investigated by measuring the paired-pulse ratio (PPR) after a paired-pulse protocol (e.g., Baldelli et al. 2005; Bolshakov and Siegelbaum 1995; Dunwiddie and Hass 1985; Guzman et al. 2003; Ibañez-Sandoval et al. 2006; Kamiya and Zucker 1994; Salgado et al. 2005; Zucker 1999) (see METHODS). As shown in Fig. 4, C and D, the depression of EPSC amplitude that was sulpiride-resistant did not modify PPR (NS); suggesting that this action is postsynaptic (see following text). On the other hand, EPSC reduction after sulpiride removal (sulpiride-sensitive) was associated with a significant increase in PPR (Fig. 4D; n = 10; P < 0.02; Friedman's nonparametric ANOVA with pairwise comparisons using Student–Newman–Keuls test), suggesting that it was the result of a presynaptic location of the D2/3-type receptor.
Postsynaptic EPSC reduction is the result of a D4-type receptor
D4-type receptors are expressed in GP neurons (Ariano et al. 1997; Mauger et al. 1998; Mrzljak et al. 1996; Shin et al. 2003). Therefore a logical hypothesis would imply such receptors to explain the sulpiride-resistant reduction of the subthalamopallidal EPSC by dopamine and quinpirole. To test this hypothesis, we explored whether the blockade of D4-type receptors prevented the sulpiride-resistant reduction of the subthalamopallidal EPSC by quinpirole. Experiments were done in the presence of sulpiride to eliminate the participation of D2/3 receptors. As seen in Fig. 5, L-745,870 (1 µM), a D4-type receptor antagonist 2,000- and 5,000-fold more selective for the D4 over D2- and D3-type receptors, respectively (Kulagowski et al. 1996; Patel et al. 1997), completely blocked the sulpiride-resistant action induced by quinpirole. The EPSC amplitude was 85 ± 11 pA in the control and 88 ± 11 pA in quinpirole plus L-745,870, in the presence of sulpiride (n = 7; NS; Friedman's test). Subsequent removal of the D4 antagonist allowed a reduction of the EPSC by quinpirole (16%) in the continuous presence of sulpiride, to 72 ± 8 pA (Fig. 5B; n = 7; P < 0.006; Wilcoxon's t-test), thus confirming the presence of a sulpiride-resistant action in GP cells.
PD 168,077 (1 µM), a selective D4-type receptor agonist with >300-fold selectivity over D3- and >400-fold selectivity over D2-type receptors (Glase et al. 1997), was also tested to confirm the participation of D4-type receptors in the dopaminergic modulation of subthalamopallidal EPSCs. In this case, too, the participation of D2/3 receptors was prevented by sulpiride (1 µM). The effect of the D4 agonist was studied first, in the presence and then in the absence of the selective D4 antagonist L-745,870 (1 µM). As shown in Fig. 6, A and B, L-745,870 (antagonist) blocked the effect of PD 168,077 (agonist) when administered together. EPSC amplitude was 100 ± 11 pA in the control and 105 ± 11 pA after addition of D4 agonist PD 168,077 in the presence of D4 antagonist L-745,870 and D2/3 antagonist sulpiride (Fig. 6, A and B; n = 7; NS; Friedman's test). However, the agonist PD 168,077 reduced the EPSC after the antagonist L-745,870 was removed from the bath in the continuous presence of sulpiride. Reduction of EPSC was about 26%, to 74 ± 7 pA (Fig. 6, A and B; n = 7; **P < 0.03; Wilcoxon's t-test). The effect of PD 168,077 was reversible. EPSC reduction induced by PD 168,077 was not accompanied by any change in PPR (Fig. 6, C and D; n = 6; NS; Wilcoxon's t-test), consistent with a postsynaptic site of action.
Activation of D2/3 receptors reduces the frequency but not the amplitude of sEPSCs
Taken together, experimental evidence suggested that D2/3 receptors have a presynaptic locus, whereas D4 receptors have a postsynaptic one. To further test this hypothesis, the actions of D2-class dopamine agonists were tested on spontaneous synaptic currents (sEPSCs) recorded on GP neurons in the presence of TTX (1 µM). Participation of 
-aminobutyric acid type A (GABAA) and D4-type receptors was excluded by the addition of bicuculline (30 µM) and L-745,870 (1 µM) administered together in the bathing medium. In these conditions, quinpirole (1 µM) significantly reduced the frequency of sEPSCs, from 1.3 ± 0.4 Hz in the control to 0.9 ± 0.2 Hz in the presence of quinpirole (Fig. 7, A, D, and E; n = 7; P < 0.04; n = 8; Wilcoxon's t-test). However, quinpirole in the same conditions did not significantly alter the mean amplitude of the sEPSCs: from 14 ± 1 pA in the control to 13 ± 2 pA in quinpirole (Fig. 7, B and C).
Activation of D4 receptors reduces the amplitude but not the frequency of sEPSCs
To study the activation of D4-type receptors on sEPSCs, sulpiride (1 µM) was added to the medium to rule out participation of D2/3-type receptors, together with bicuculline (30 µM) to block GABAA receptors, and TTX (1 µM) to block synaptic currents produced by neuronal firing. In these conditions, the D4-agonist PD 168,077 significantly reduced the amplitude of sEPSCs, from 11 ± 0.8 to 8 ± 0.7 pA (Fig. 8, B and C; n = 8; P < 0.002; Wilcoxon's t-test). However, the mean frequency of sEPSCs was not significantly altered, from 1.4 ± 0.5 to 1.5 ± 0.4 Hz in the presence of PD 168,077 (Fig. 8, D and E).
Taken together, the results are consistent with a presynaptic location of D2/3-type receptors and a postsynaptic location of D4-type receptors.
Variance–mean analysis of dopaminergic synaptic modulation in the GP
Variance–mean analysis (Clements and Silver 2000; Reid and Clements 1999) was used as an independent test to assess the sites where dopaminergic receptors were exerting their modulatory actions on the subthalamopallidal EPSC (see Ibañez-Sandoval et al. 2006; Salgado et al. 2005). Trains of 50 Hz each eliciting 10 EPSCs were evoked by stimulating the subthalamopallidal pathway during recording of GP neurons. Trains were evoked every 10 s (Fig. 9, A and C; see METHODS). With these parameters, the type of short-term dynamics recorded in control conditions was short-term depression (STD) even if the frequency used allowed some temporal summation (Fig. 9, A and C, top, control).
The effect of activation of D2/3 receptors was studied administering the D2-class agonist quinpirole (1 µM) together with the selective D4 receptor antagonist L-745,870 (1 µM) in the presence of bicuculline (see above). Activation of D2/3 receptors reduced the amplitude of first events but not of secondary events (cf. Fig. 9A, top with Fig. 9A, middle and bottom). The variance–mean relationships (V–M plots) (Fig. 9B) (Clements and Silver 2000) show that most control (filled circles) and quinpirole data points (empty circles) cluster together at the initial part of the fitted parabolas. In fact, weighted quantal amplitudes (Qw; Eq. 2 in METHODS) were 5 ± 0.6 pA for the control and 5 ± 0.3 pA after activation of D2/3-type receptors (range = 4–9 pA; n = 4 different experiments; NS; Student's t-test), similar to quantal amplitudes found in the subthalamonigral pathway (Ibañez-Sandoval et al. 2006) and other glutamatergic synapses of the CNS (Bolshakov and Siegelbaum 1995; Paulsen and Heggelund 1994). These results agree with those showing a lack of change in mean sEPSC amplitude (Fig. 7, A–C). In contrast, the presynaptic parameter N (Eq. 3) showed a difference from 44 ± 2 in the control to 31 ± 2 after D2/3-receptor activation (P < 0.005; Student's t-test) (Reid and Clements 1999).
On the other hand, although activation of D4 receptors with the selective D4 agonist (1 µM PD 168,077) in the presence of sulpiride (1 µM) also reduced the first EPSC in the train, amplitudes of the secondary events were also reduced (cf. Fig. 9C, top with Fig. 9C, middle and bottom). The V–M plots (Fig. 9D) thus showed that fitted parabolas (control = filled circles and black line; PD 168,077 = empty circles and gray line) diverged in their initial slopes (Fig. 9D). Thus weighted quantal amplitudes for both data sets were Qw = 5 ± 0.3 pA for the control and 4 ± 0.2 pA after D4-receptor activation (Fig. 9D; P < 0.04; Student's t-test). These results agree with those found in experiments such as those in Fig. 8, A–C, which showed a change in mean sEPSCs arising from D4-receptor activation. Because the change in the width of fitted functions was accompanied with a change in initial slope, calculations of the presynaptic parameter N did not show any difference: 24 ± 2 in the control versus 23 ± 2 in PD 168,077 (Clements and Silver 2000). Further quantal analysis may be performed in the future to assess agonist effects on release probabilities because average probabilities (Eq. 4) did not show any difference with this analysis (e.g., Salgado et al. 2005). For the goals of the present work, however, variance–mean analysis was consistent with the view that dopaminergic modulation of subthalamopallidal transmission occurs at both presynaptic (D2/3 receptors) and postsynaptic sites (D4 receptors).
|
|
DISCUSSION |
|---|
|
; Plenz and Kitai 1999; Terman et al. 2002). In this work, biocytin anterograde and retrograde labeling, as well as antidromic activation, demonstrated that some reciprocal connections between GP and STN (Gandia et al. 1993; Hazrati and Parent 1992; Kita and Kita 1991, 2001; Kita et al. 2004; Nambu et al. 2000; Parent et al. 2000; Sato et al. 2000b; Shink et al. 1996; Shinonaga et al. 1992; Smith et al. 1990) can functionally be preserved in in vitro slice preparations (Beurrier et al. 2006; Hanson and Jaeger 2002: Ogura and Kita 2000). Furthermore, moderate-strength orthodromic stimulation of the subthalamopallidal pathway in the presence of bicuculline to block inhibitory inputs and intracellular QX-314 to block unclamped action currents in the recorded cell can isolate single excitatory postsynaptic currents (EPSCs) that, at –80 mV holding potential, were mostly the product of AMPA/kainate receptor activation (Ogura and Kita 2000). The main finding of this work was that dopamine in the globus pallidus, presynaptically and postsynaptically, modulates this excitatory subthalamopallidal input. Both D2/3- and D4-type receptors participate, thus decreasing the magnitude of the synaptic response. D2/3-type receptors appear to be located presynaptically on subthalamopallidal afferents, whereas D4-type receptors appear to be located postsynaptically on GP neurons. Physiologically, both receptors appear to act simultaneously to control the excitatory tone and the firing of GP neurons. Because STN also projects to the subtantia nigra pars compacta (Iribe et al. 1999; Kanazawa et al. 1976; Smith and Grace 1992), the results then suggest that subthalamic efferents to the GP may autocontrol their output through the simultaneous activation of dopaminergic modulation. Presynaptic control of subthalamic inputs by D2/3 receptors
Subthalamic neurons express both D1-class and D2-class receptors (Baufreton et al. 2003; Ciliax et al. 2000; Dawson et al. 1986; Flores et al. 1999; Hurd et al. 2001; Johnson et al. 1994; Svenningsson and Le Moine 2002), which mediate dopamine actions that modulate the firing of STN neurons (Baufreton et al. 2003; Kreiss et al. 1996, 1997; Mintz et al. 1986; Ni et al. 2001; Svenningsson and Le Moine 2002; Zhu et al. 2002). Both receptor classes may be transported to the synaptic terminals of axons arising from STN projection neurons, for example, to presynaptically modulate subthalamonigral inputs to the reticulata (Ibañez-Sandoval et al. 2006). This suggests that they could also be present in the terminals of the subthalamopallidal efferents.
In the present work we chose to study the subthalamopallidal modulation by D2-class receptors only. This decision was influenced by the fact that GP neurons express D4-type receptors (Ariano et al. 1997; Floran et al. 2004; Mauger et al. 1998; Mrzljak et al. 1996) and it was previously shown that D4 receptors located on GP neurons exert an inhibitory control on GABAergic inputs (Shin et al. 2003). Moreover, the GP also receives glutamatergic excitatory inputs from the thalamus (Mouroux et al. 1997; Yasukawa et al. 2004). Although thalamic afferents do not express D2/3 receptors, they may express D5-type receptors (Meador-Woodruff et al. 1992), which may also be the most important type of D1-class receptor present in STN neurons (Baufreton et al. 2003; Ciliax et al. 2000; Svenningsson and Le Moine 2002). Therefore modulation by D1- or D2-class receptors needs to be carefully separated to understand their actions in the GP.
This work reports that both dopamine and quinpirole, the D2-class nonselective receptor agonist, reduced the subthalamopallidal-evoked EPSCs. In both cases this reduction was only partially blocked by the D2/3 receptor antagonist sulpiride, thus revealing a potentially important sulpiride-resistant action of dopamine D2-class agonists. Even at high concentrations (e.g., 10 µM) sulpiride does not block D4 receptors (Price and Pittman 2001; Shin et al. 2003; Wang et al. 2002) and, because GP neurons express D4-type receptors, it was logical to hypothesize that the sulpiride-resistant action was mediated by D4 receptors (see following text).
The sulpiride-sensitive action could then be mediated by D2/3 receptors located in the subthalamopallidal pathway (Cooper and Stanford 2001; Ibañez-Sandoval et al. 2006). The present work supported this hypothesis with three kinds of experimental evidence. First, the sulpiride-sensitive reduction of synaptic currents was associated with a change in the paired-pulse ratio, consistent with a presynaptic site of action (e.g., Baldelli et al. 2005; Dunwiddie and Haas 1985; Guzman et al. 2003; Ibañez-Sandoval et al. 2006; Kamiya and Zucker 1994; Price and Pittman 2001; Salgado et al. 2005; Zucker 1999). Second, selective activation of D2/3 receptors changed the frequency but not the amplitude of sEPSCs (Cooper and Stanford 2001; Koga and Momiyama 2000; see also Mann-Metzer and Yarom 2002; Sahara and Takahashi 2001). Finally, variance–mean analysis (Clements and Silver 2000; Ibañez-Sandoval et al. 2006; Koos et al. 2004; Reid and Clements 1999; Salgado et al. 2005) suggested that selective activation of D2/3 receptors did not change the quantal amplitude. Instead, the parameter that was different in the fitted function (N) was consistent with a presynaptic change (Eq. 3; see METHODS).
Postsynaptic control of subthalamic inputs by D4 receptors
The hypothesis that the sulpiride-resistant action was mediated by D4 receptors located postsynaptically on GP neurons was supported by three types of experiments. First, selective activation of D4 receptors reduced subthalamopallidal EPSCs without changing the paired-pulse ratio. Second, D4 receptor activation reduced the mean amplitude of sEPSCs without affecting the frequency. Finally, variance–mean analysis revealed a significant reduction in quantal amplitude without affecting any presynaptic parameter.
To conclude, both D2/3 and D4 type receptors modulate the subthalamopallidal response. Nevertheless, D2/3-type receptors exert their modulation acting presynaptically, whereas D4-type receptors modulate the inputs from the postsynaptic side.
Possible physiological consequences
Dopamine actions in the GP are necessary to achieve motor control (Pan and Walters 1988; Raz et al. 2000). Bilateral infusions of D1- or D2-class receptor antagonists into the GP induce akinesia and catalepsia (Costall and Naylor 1972; Hauber and Lutz 1999). However, the infusion of dopamine in the same nucleus causes amelioration of motor deficits in hemiparkinsonian rats (Galvan et al. 2001). It is then important to know the actions of dopamine in the GP.
The GP and the STN assemble a reciprocally innervated network of excitatory and inhibitory neurons (Bevan et al. 2002b; Gandia et al. 1993; Hazrati and Parent 1992; Kita and Kita 1991, 2001; Kita et al. 2004; Nambu et al. 2000; Parent et al. 2000; Sato et al. 2000a,b; Shink et al. 1996; Shinonaga et al. 1992; Smith et al. 1990). Because of the intrinsic properties of GP and STN neurons (Beurrier et al. 1999, 2000; Bevan and Wilson 1999; Bevan et al. 2002a; Chan et al. 2004; Cooper and Stanford 2000; Hallworth et al. 2003; Kita and Kitai 1991; Kita et al. 2004; Nambu and Llinas 1994; Overton and Greenfield 1995), this network forms a robust central pattern generator (CPG) in the basal ganglia (Grillner 2003; Terman et al. 2002; Yuste et al. 2005). Diverse spatiotemporal patterns of rhythmic and synchronous oscillatory activity can arise when the levels of inhibitory or excitatory inputs impinging onto this network are varied (Bevan and Wilson 1999; Bevan et al. 2002b; Kita et al. 2004; Overton and Greenfield 1995; Plenz and Kitai 1999; Terman et al. 2002; Urbain et al. 2000). The present and previous (Cooper and Stanford 2001; Floran et al. 1997) findings showed that the levels of inhibitory and excitatory inputs impinging onto GP neurons depend on dopaminergic modulation. Therefore it is logical to infer that the variety of spatiotemporal patterns of oscillatory activity that this network exhibits to produce motor organization may be a product of dopaminergic modulation. Perhaps, a detailed somatotopic organization of dopaminergic neurons in the compacta determines, according to the afferents active during a motor task, which inputs increase and which decrease their strength. If dopamine modulation is lost, however, a dramatic reduction in the possible patterns is obtained. The system then becomes locked in a few extreme and robust set of variations (Bergman et al. 1994; Brown et al. 2001; Levy et al. 2002; Magill et al. 2001; Magnin et al. 2000; Nini et al. 1995; Raz et al. 2000).
|
|
GRANTS |
|---|
|
|
|
ACKNOWLEDGMENTS |
|---|
|
|
|
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: J. Bargas, Biofísica, Instituto de Fisiología Celular, UNAM, PO Box 70-253, Mexico City, DF 04510 Mexico (E-mail: jbargas{at}ifc.unam.mx)
|
|
REFERENCES |
|---|
|
Baldelli P, Hernandez-Guijo JM, Carabelli V, and Carbone E. Brain-derived neurotrophic factor enhances GABA release probability and nonuniform distribution of N- and P/Q-type channels on release sites of hippocampal inhibitory synapses. J Neurosci 25: 3358–3368, 2005.
Baufreton J, Garret M, Rivera A, de la Calle A, Gonon F, Dufy B, Bioulac B, and Taupignon A. D5 (not D1) dopamine receptors potentiate burst-firing in neurons of the subthalamic nucleus by modulating an L-type calcium conductance. J Neurosci 23: 816–825, 2003.
Beckstead RM. A pallidostriatal projection in the cat and monkey. Brain Res Bull 11: 629–632, 1983.[CrossRef][Web of Science][Medline]
Bergman H, Wichmann T, Karmon B, and DeLong MR. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol 72: 5507–5520, 1994.
Beurrier C, Ben-Ari Y, and Hammond C. Preservation of the direct and indirect pathways in an in vitro preparation of the mouse basal ganglia. Neuroscience 140: 77–86, 2006.[CrossRef][Web of Science][Medline]
Beurrier C, Bioulac B, and Hammond C. Slowly inactivating sodium current (INaP) underlies single-spike activity in rat subthalamic neurons. J Neurophysiol 83: 1951–1957, 2000.
Beurrier C, Congar P, Bioulac B, and Hammond C. Subthalamic nucleus neurons switch from single-spike activity to burst-firing mode. J Neurosci 19: 599–609, 1999.
Bevan MD, Magill PJ, Hallworth NE, Bolam JP, and Wilson CJ. Regulation of the timing and pattern of action potential generation in rat subthalamic neurons in vitro by GABA-A IPSPs. J Neurophysiol 87: 1348–1362, 2002a.
Bevan MD, Magill PJ, Terman D, Bolam JP, and Wilson CJ. Move to the rhythm: oscillations in the subthalamic nucleus-external globus pallidus network. Trends Neurosci 25: 525–531, 2002b.[CrossRef][Web of Science][Medline]
Bevan MD and Wilson CJ.Mechanisms underlying spontaneous oscillation and rhythmic firing in rat subthalamic neurons. J Neurosci 19: 7617–7628, 1999.
Bolshakov VY and Siegelbaum SA. Regulation of hippocampal transmitter release during development and long-term potentiation. Science 269: 1730–1734, 1995.
Brown P, Oliviero A, Mazzone P, Insola A, Tonali P, and Di Lazzaro V. Dopamine dependency of oscillations between subthalamic nucleus and pallidum in Parkinson's disease. J Neurosci 21: 1033–1038, 2001.
Chan CS, Shigemoto R, Mercer JN, and Surmeier DJ. HCN2 and HCN1 channels govern the regularity of autonomous pacemaking and synaptic resetting in globus pallidus neurons. J Neurosci 24: 9921–9932, 2004.
Ciliax BJ, Nash N, Heilman C, Sunahara R, Hartney A, Tiberi M, Rye DB, Caron MG, Niznik HB, and Levey AL. Dopamine D5 receptor immunolocalization in rat and monkey brain. Synapse 37: 125–145, 2000.[CrossRef][Web of Science][Medline]
Clements JD and Silver RA. Unveiling synaptic plasticity: a new graphical and analytical approach. Trends Neurosci 23: 105–113, 2000.[CrossRef][Web of Science][Medline]
Cooper AJ and Stanford IM. Electrophysiological and morphological characteristics of three subtypes of rat globus pallidus neurone in vitro. J Physiol 527: 291–304, 2000.
Cooper AJ and Stanford IM. Dopamine D2 receptor mediated presynaptic inhibition of striatopallidal GABAA IPSCs in vitro. Neuropharmacology 41: 62–71, 2001.[CrossRef][Web of Science][Medline]
Costall B, Naylor RJ, and Olley JF. On the involvement of the caudate-putamen, globus pallidus and substantia nigra with neuroleptic and cholinergic modification of locomotor activity. Neuropharmacology 11: 317–330, 1972.[CrossRef][Web of Science][Medline]
Dawson TM, Gehlert DR, McCabe RT, Barnett A, and Wamsley JK. D1 dopamine receptors in the rat brain: a quantitative autoradiographic analysis. J Neurosci 6: 2352–2365, 1986.[Abstract]
Debeir T, Ginestet L, Francois C, Laurens S, Martel JC, Chopin P, Marien M, Colpaert F, and Raiman-Vozari R. Effect of intrastriatal 6-OHDA lesion on dopaminergic innervation of the rat cortex and globus pallidus. Exp Neurol 193: 444–454, 2005.[CrossRef][Web of Science][Medline]
DeLong MR, Crutcher MD, and Georgopoulos AP. Primate globus pallidus and subthalamic nucleus: functional organization. J Neurophysiol 53: 530–543, 1995.
Dunwiddie TV and Haas HL. Adenosine increases synaptic facilitation in the in vitro rat hippocampus: evidence for a presynaptic site of action. J Physiol 369: 365–377, 1985.
Engler B, Freiman I, Urbanski M, and Szabo B. Effects of exogenous and endogenous cannabinoids on GABAergic neurotransmission between the caudate-putamen and the globus pallidus in the mouse. J Pharmacol Exp Ther 316: 608–617, 2006.
Floran B, Floran L, Erlij D, and Aceves J. Dopamine D4 receptors inhibit depolarization-induced [3H]GABA release in the rat subthalamic nucleus. Eur J Pharmacol 498: 97–102, 2004.[CrossRef][Web of Science][Medline]
Floran B, Floran L, Sierra A, and Aceves J. D2 receptor mediated inhibition of GABA release by endogenous dopamine in the rat globus pallidus. Neurosci Lett 237: 1–4, 1997.[CrossRef][Web of Science][Medline]
Flores G, Liang JJ, Sierra A, Martinez-Fong D, Quirion R, Aceves J, and Srivastava LK. Expression of dopamine receptors in the subthalamic nucleus of the rat: characterization using reverse transcriptase-polymerase chain reaction and autoradiography. Neuroscience 91: 549–556, 1999.[CrossRef][Web of Science][Medline]
Fonnum F, Gottesfeld Z, and Grofova I. Distribution of glutamate decarboxylase, choline acetyl-transferase and aromatic amino acid decarboxylase in the basal ganglia of normal and operated rats. Evidence for striatopallidal, striatoentopeduncular and striatonigral GABAergic fibres. Brain Res 143: 125–138, 1978.[CrossRef][Web of Science][Medline]
Galvan A, Floran B, Erlij D, and Aceves J. Intrapallidal dopamine restores motor deficits induced by 6-hydroxydopamine in the rat. J Neural Transm 108: 153–166, 2001.[CrossRef][Web of Science][Medline]
Gandia JA, De Las Heras S, Garcia M, and Gimenez-Amaya JM. Afferent projections to the reticular thalamic nucleus from the globus pallidus and the substantia nigra in the rat. Brain Res Bull 32: 351–358, 1993.[CrossRef][Web of Science][Medline]
Gauthier J, Parent M, Levesque M, and Parent A. The axonal arborization of single nigrostriatal neurons in rats. Brain Res 834: 228–232, 1999.[CrossRef][Web of Science][Medline]
Gimenez-Amaya JM, and Graybiel AM. Compartmental origins of the striatopallidal projection in the primate. Neuroscience 34: 111–126, 1990.[CrossRef][Web of Science][Medline]
Glase SA, Akunne HC, Georgic LM, Heffner TG, MacKenzie RG, Manley PJ, Pugsley TA, and Wise LD. Substituted [(4-phenylpiperazinyl)-methyl]benzamide: selective dopamine D4 agonists. J Med Chem 40: 1771–1772, 1997.[CrossRef][Web of Science][Medline]
Grillner S. The motor infrastructure: from ion channels to neuronal networks. Nat Rev Neurosci 4: 573–586, 2003.[Web of Science][Medline]
Guzman JN, Hernandez A, Galarraga E, Laville A, Vergara R, Aceves J, and Bargas J. Dopaminergic modulation of axon collaterals interconnecting spiny neurons of the rat sriatum. J Neurosci 23: 8931–8940, 2003.
Hallworth NE, Wilson CJ, and Bevan MD. Apamin-sensitive small conductance calcium-activated potassium channels, through their selective coupling to voltage-gated calcium channels, are critical determinants of the precision, pace, and pattern of action potential generation in rat subthalamic nucleus neurons in vitro. J Neurosci 23: 7525–7542, 2003.
Hanson JE and Jaeger D. Short-term plasticity shapes the response to simulated normal and parkinsonian input patterns in the globus pallidus. J Neurosci 22: 5164–5172, 2002.
Hauber W and Lutz S. Dopamine D1 or D2 receptor blockade in the globus pallidus produces akinesia in the rat. Behav Brain Res 106: 143–150, 1999.[CrossRef][Web of Science][Medline]
Hazrati LN and Parent A. Convergence of subthalamic and striatal efferents at pallidal level in primates: an anterograde double-labeling study with biocytin and PHA-L. Brain Res 569: 336–340, 1992.[CrossRef][Web of Science][Medline]
Hernandez A, Valdiosera R, Floran B, Erlij D, and Aceves J. Pre- and postsynaptic modulation of the glutamatergic transmission by dopamine in the rat globus pallidus. Soc Neurosci Abstr 46: 16, 2004.
Hoover BR and Marshall JF. Population characteristics of preproenkephalin mRNA-containing neurons in the globus pallidus of the rat. Neurosci Lett 265: 199–202, 1999.[CrossRef][Web of Science][Medline]
Hurd YL, Suzuki M, and Sedvall GC. D1 and D2 dopamine receptor mRNA expression in whole hemisphere sections of the human brain. J Chem Neuroanat 22: 127–137, 2001.[CrossRef][Web of Science][Medline]
Ibañez-Sandoval O, Hernandez A, Floran B, Galarraga E, Tapia D, Valdiosera R, Erlij D, Aceves J, and Bargas J. Control of the subthalamic innervation of substantia nigra pars reticulata by D1 and D2 dopamine receptors. J Neurophysiol 95: 1800–1811, 2006.
Iribe Y, Moore K, Pang KC, and Tepper JM. Subthalamic stimulation-induced synaptic responses in substantia nigra pars compacta dopaminergic neurons in vitro. J Neurophysiol 82: 925–933, 1999.
Johnson AE, Coirini H, Kallstrom L, and Wiesel FA. Characterization of dopamine receptor binding sites in the subthalamic nucleus. Neuroreport 5: 1836–1838, 1994.[Web of Science][Medline]
Jonas P, Major G, and Sakmann B. Quantal components of unitary EPSCs at the mossy fibre synapse on CA3 pyramidal cells of rat hippocampus. J Physiol 472: 615–663, 1993.
Kamiya H and Zucker RS. Residual Ca2+ and short-term synaptic plasticity. Nature 371: 603–606, 1994.[CrossRef][Medline]
Kanazawa I, Marshall GR, and Kelly JS. Afferents to the rat substantia nigra studied with horseradish peroxidase, with special reference to fibers from the subthalamic nucleus. Brain Res 115: 485–491, 1976.[CrossRef][Web of Science][Medline]
Kaneda K, Nambu A, Tokuno H, and Takada M. Differential processing patterns of motor information via striatopallidal and striatonigral projections. J Neurophysiol 88: 1420–1432, 2002.
Kawaguchi Y, Wilson CJ, and Emson PC. Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin. J Neurosci 10: 3421–3438, 1990.[Abstract]
Kita H and Kita T. Number, origins, and chemical types of rat pallidostriatal projection neurons. J Comp Neurol 437: 438–448, 2001.[CrossRef][Web of Science][Medline]
Kita H and Kitai ST. Intracellular study of rat globus pallidus neurons: membrane properties and responses to neostriatal, subthalamic and nigral stimulation. Brain Res 564: 296–305, 1991.[CrossRef][Web of Science][Medline]
Kita H and Kitai ST. The morphology of globus pallidus projection neurons in the rat: an intracellular staining study. Brain Res 636: 308–319, 1994.[CrossRef][Web of Science][Medline]
Kita H, Nambu A, Kaneda K, Tachibana Y, and Takada M. Role of ionotropic glutamatergic and GABAergic inputs on the firing activity of neurons in the external pallidum in awake monkeys. J Neurophysiol 92: 3069–3084, 2004.
Kita H, Tachibana Y, Nambu A, and Chiken S. Balance of monosynaptic excitatory and disynaptic inhibitory responses of the globus pallidus induced after stimulation of the subthalamic nucleus in the monkey. J Neurosci 25: 8611–8619, 2005.
Koga E and Momiyama T. Presynaptic dopamine D2-like receptors inhibit excitatory transmission onto rat ventral tegmental dopaminergic neurons. J Physiol 523: 163–173, 2000.
Koos T, Tepper JM, and Wilson CJ. Comparison of IPSCs evoked by spiny and fast-spiking neurons in the neostriatum. J Neurosci 24: 7916–7922, 2004.
Kreiss DS, Anderson LA, and Walters JR. Apomorphine and dopamine D1 receptor agonists increase the firing rates of subthalamic nucleus neurons. Neuroscience 72: 863–876, 1996.[CrossRef][Web of Science][Medline]
Kreiss DS, Mastropietro CW, Rawji SS, and Walters JR. The response of subthalamic nucleus neurons to dopamine receptor stimulation in a rodent model of Parkinson's disease. J Neurosci 17: 6807–6819, 1997.
Kulagowski JJ, Broughton HB, Curtis NR, Mawer IM, Ridgill MP, Baker R, Emms F, Freedman SB, Marwood R, Patel S, Ragan CI, and Leeson PD. 3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptor. J Med Chem 39: 1941–1942, 1996.[CrossRef][Web of Science][Medline]
Levy R, Ashby P, Hutchison WD, Lang AE, Lozano AM, and Dostrovsky JO. Dependence of subthalamic nucleus oscillations on movement and dopamine in Parkinson's disease. Brain 125: 1196–1209, 2002.
Lindvall O and Björklund A. Dopaminergic innervation of the globus pallidus by collaterals from the nigrostriatal pathway. Brain Res 172: 169–173, 1979.[CrossRef][Web of Science][Medline]
Magill PJ, Bolam JP, and Bevan MD. Dopamine regulates the impact of the cerebral cortex on the subthalamic nucleus-globus pallidus network. Neuroscience 106: 313–330, 2001.[CrossRef][Web of Science][Medline]
Magnin M, Morel A, and Jeanmonod D. Single-unit analysis of the pallidum, thalamus and subthalamic nucleus in parkinsonian patients. Neuroscience 96: 549–564, 2000.[CrossRef][Web of Science][Medline]
Mann-Metzer P and Yarom Y. Pre- and postsynaptic inhibition mediated by GABAB receptors in cerebellar inhibitory interneurons. J Neurophysiol 87: 183–190, 2002.
Mauger C, Silvan B, Brockhaus M, Fuchs S, Civelli O, and Monsma F Jr. Development and characterization of antibodies directed against the mouse D4 dopamine receptor. Eur J Neurosci 10: 529–537, 1998.[CrossRef][Web of Science][Medline]
Meador-Woodruff JH, Mansour A, Grandy DK, Damask SP, Civelli O, and Watson SJ Jr. Distribution of D5 dopamine receptor mRNA in rat brain. Neurosci Lett 145: 209–212, 1992.[CrossRef][Web of Science][Medline]
Mintz I, Hammond C, and Feger J. Excitatory effect of iontophoretically applied dopamine on identified neurons of the rat subthalamic nucleus. Brain Res 375: 172–175, 1986.[CrossRef][Web of Science][Medline]
Mitchell SJ, Richardson RT, Baker FH, and DeLong MR. The primate globus pallidus: neuronal activity related to direction of movement. Exp Brain Res 68: 491–505, 1987.[Web of Science][Medline]
Mouroux M, Hassani OK, and Feger J. Electrophysiological and Fos immunohistochemical evidence for the excitatory nature of the parafascicular projection to the globus pallidus. Neuroscience 81: 387–397, 1997.[CrossRef][Web of Science][Medline]
Mrzljak L, Bergson C, Pappy M, Huff R, and n-Rakic PS. Localization of dopamine D4 receptors in GABAergic neurons of the primate brain. Nature 381: 245–248, 1996.[CrossRef][Medline]
Nakanishi H, Hori N, and Kastuda N. Neostriatal evoked inhibition and effects of dopamine on globus pallidal neurons in rat slice preparations. Brain Res 358: 282–286, 1985.[CrossRef][Web of Science][Medline]
Nambu A and Llinas R. Electrophysiology of globus pallidus neurons in vitro. J Neurophysiol 72: 1127–1139, 1994.
Nambu A and Llinas R. Morphology of globus pallidus neurons: its correlation with electrophysiology in guinea pig brain slices. J Comp Neurol 377: 85–94, 1997.[CrossRef][Web of Science][Medline]
Nambu A, Tokuno H, Hamada I, Kita H, Imanishi M, Akazawa T, Ikeuchi Y, and Hasegawa N. Excitatory cortical inputs to pallidal neurons via the subthalamic nucleus in the monkey. J Neurophysiol 84: 289–300, 2000.
Ni Z, Gao D, Bouali-Benazzouz R, Benabid AL, and Benazzouz A. Effect of microiontophoretic application of dopamine on subthalamic nucleus neuronal activity in normal rats and in rats with unilateral lesion of the nigrostriatal pathway. Eur J Neurosci 14: 373–381, 2001.[CrossRef][Web of Science][Medline]
Nini A, Feingold A, Slovin H, and Bergman H. Neurons in the globus pallidus do not show correlated activity in the normal monkey, but phase-locked oscillations appear in the MPTP model of parkinsonism. J Neurophysiol 74: 1800–1805, 1995.
Ogura M and Kita H. Dynorphin exerts both postsynaptic and presynaptic effects in the globus pallidus of the rat. J Neurophysiol 83: 3366–3376, 2000.
Overton PG and Greenfield SA. Determinants of neuronal firing pattern in the guinea-pig subthalamic nucleus: an in vivo and in vitro comparison. J Neural Transm 10: 41–54, 1995.
Pan HS and Walters JR. Unilateral lesion of the nigrostriatal pathway decreases the firing rate and alters the firing pattern of globus pallidus neurons in the rat. Synapse 2: 650–656, 1988.[CrossRef][Web of Science][Medline]
Parent A, Bouchard C, and Smith Y. The striatopallidal and striatonigral projections: two distinct fiber systems in primate. Brain Res 303: 385–390, 1984.[CrossRef][Web of Science][Medline]
Parent A, Sato F, Wu Y, Gauthier J, Lévesque M, and Parent M. Organization of the basal ganglia: the importance of axonal collateralization. Trends Neurosci 23: S20–S27, 2000.[CrossRef][Web of Science][Medline]
Patel S, Freedman S, Chapman KL, Emms F, Fletcher AE, Knowles M, Marwood R, Mcallister G, Myers J, Curtis N, Kulagowski JJ, Leeson PD, Ridgill M, Graham M, Matheson S, Rathbone D, Watt AP, Bristow LJ, Rupniak NM, Baskin E, Lynch JJ, and Ragan CI. Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptor. J Pharmacol Exp Ther 283: 636–647, 1997.
Paulsen O and Heggelund P. The quantal size at retinogeniculate synapses determined from spontaneous and evoked EPSCs in guinea-pig thalamic slices. J Physiol 480: 505–511, 1994.
Plenz D and Kitai ST. A basal ganglia pacemaker formed by the subthalamic nucleus and external globus pallidus. Nature 400: 677–682, 1999.[CrossRef][Medline]
Prensa L and Parent A. The nigrostriatal pathway in the rat: a single-axon study of the relationship between dorsal and ventral tier nigral neurons and the striosome/matrix striatal compartments. J Neurosci 21: 7247–7260, 2001.
Price CJ and Pittman QJ. Dopamine D4 receptor activation inhibits presynaptically glutamatergic neurotransmission in the rat supraoptic nucleus. J Neurophysiol 86: 1149–1155, 2001.
Querejeta E, Delgado A, Valdiosera R, Erlij D, and Aceves J. Intrapallidal D2 dopamine receptors control globus pallidus neuron activity in the rat. Neurosci Lett 300: 79–82, 2001.[CrossRef][Web of Science][Medline]
Rajakumar N, Rushlow W, Naus CC, Elisevich K, and Flumerfelt BA. Neurochemical compartmentalization of the globus pallidus in the rat: an immunocytochemical study of calcium-binding proteins. J Comp Neurol 346: 337–348, 1994.[CrossRef][Web of Science][Medline]
Raz A, Vaadia E, and Bergman H. Firing patterns and correlations of spontaneous discharge of pallidal neurons in the normal and the tremulous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet model of parkinsonism. J Neurosci 20: 8559–8571, 2000.
Reid CA and Clements JD. Postsynaptic expression of long-term potentiation in the rat dentate gyrus demonstrated by variance-mean analysis. J Physiol 518: 121–130, 1999.
Ruskin DN and Marshall JF. Differing influences of dopamine agonists and antagonists on Fos expression in identified populations of globus pallidus neurons. Neuroscience 81: 79–92, 1997.[CrossRef][Web of Science][Medline]
Sahara Y and Takahashi T. Quantal components of the excitatory postsynaptic currents at a rat central auditory synapse. J Physiol 536: 189–197, 2001.
Salgado H, Tecuapetla F, Perez-Rosello T, Perez-Burgos A, Perez-Garci E, Galarraga E, and Bargas J. A reconfiguration of CaV2 Ca2+ channels current and its dopaminergic D2 modulation in developing neostriatal neurons. J Neurophysiol 94: 3771–3787, 2005.
Sato F, Lavallee P, Levesque M, and Parent A. Single-axon tracing study of neurons of the external segment of the globus pallidus in primate. J Comp Neurol 417: 17–31, 2000a.[CrossRef][Web of Science][Medline]
Sato F, Parent M, Levesque M, and Parent A. Axonal branching pattern of neurons of the subthalamic nucleus in primates. J Comp Neurol 424: 142–152, 2000b.[CrossRef][Web of Science][Medline]
Shin RM, Masuda M, Miura M, Sano H, Shirasawa T, Song WJ, Kobayashi K, and Aosaki T. Dopamine D4 receptor-induced postsynaptic inhibition of GABAergic currents in mouse globus pallidus neurones. J Neurosci 23: 11662–11672, 2003.
Shink E, Bevan MD, Bolam JP, and Smith Y. The subthalamic nucleus and the external pallidum: two tightly interconnected structures that control the output of the basal ganglia in the monkey. Neuroscience 73: 335–357, 1996.[CrossRef][Web of Science][Medline]
Shinonaga Y, Takada M, Ogawa-Meguro R, Ikai Y, and Mizuno N. Direct projections from the globus pallidus to the midbrain and pons in the cat. Neurosci Lett 135: 179–183, 1992.[CrossRef][Web of Science][Medline]
Smith ID and Grace AA. Role of the subthalamic nucleus in the regulation of nigral dopamine neuron activity. Synapse 12: 287–303, 1992.[CrossRef][Web of Science][Medline]
Smith Y, Hazrati LN, and Parent A. Efferent projections of the subthalamic nucleus in the squirrel monkey as studied by the PHA-L anterograde tracing method. J Comp Neurol 294: 306–323, 1990.[CrossRef][Web of Science][Medline]
Svenningsson P and Le Moine C. Dopamine D1/5 receptor stimulation induces c-fos expression in the subthalamic nucleus: possible involvement of local D5 receptors. Eur J Neurosci 15: 133–142, 2002.[CrossRef][Web of Science][Medline]
Terman D, Rubin JE, Yew AC, and Wilson CJ. Activity patterns in a model for the subthalamopallidal network of the basal ganglia. J Neurosci 22: 2963–2976, 2002.
Tremblay L and Filion M. Responses of pallidal neurons to striatal stimulation in intact waking monkeys. Brain Res 498: 1–16, 1989.[CrossRef][Web of Science][Medline]
Turner RS, Grafton ST, Votaw JR, Delong MR, and Hoffman JM. Motor subcircuits mediating the control of movement velocity: a PET study. J Neurophysiol 80: 2162–2176, 1998.
Urbain N, Gervasoni D, Souliere F, Lobo L, Rentero N, Windels F, Astier B, Savasta M, Fort P, Renaud B, Luppi PH, and Chouvet G. Unrelated course of subthalamic nucleus and globus pallidus neuronal activities across vigilance states in the rat. Eur J Neurosci 12: 3361–3374, 2000.[CrossRef][Web of Science][Medline]
Vergara R, Rick C, Hernandez-Lopez S, Laville JA, Guzman JN, Galarraga E, Surmeier DJ, and Bargas J. Spontaneous voltage oscillations in striatal projection neurons in a rat corticostriatal slice. J Physiol 553: 169–182, 2003.
Voorn P, van de Witte S, Tjon G, and Jonker AJ. Expression of enkephalin in pallido-striatal neurons. Ann NY Acad Sci 877: 671–675, 1999.[CrossRef][Web of Science][Medline]
Wang X, Zhong P, and Yan Z. Dopamine D4 receptors modulate GABAergic signaling in pyramidal neurons of prefrontal cortex. J Neurosci 22: 9185–9193, 2002.
Windels F, Carcenac C, Poupard A, and Savasta M. Pallidal origin of GABA release within the substantia nigra pars reticulata during high-frequency stimulation of the subthalamic nucleus. J Neurosci 25: 5079–5086, 2005.
Yasukawa T, Kita T, Xue Y, and Kita H. Rat intralaminar thalamic nuclei projections to the globus pallidus: a biotinylated dextran amine anterograde tracing study. J Comp Neurol 471: 153–167, 2004.[CrossRef][Web of Science][Medline]
Yuste R, MacLean JN, Smith J, and Lansner A. The cortex as a central pattern generator. Nat Rev Neurosci 6: 477–483, 2005.[Web of Science][Medline]
Zhu Z, Bartol M, Shen K, and Johnson SW. Excitatory effects of dopamine on subthalamic nucleus neurons: in vitro study of rats pretreated with 6-hydroxydopamine and levodopa. Brain Res 945: 31–40, 2002.[CrossRef][Web of Science][Medline]
Zucker RS. Calcium- and activity-dependent synaptic plasticity. Curr Opin Neurobiol 9: 305–313, 1999.[CrossRef][Web of Science][Medline]
This article has been cited by other articles:
|
|
 |
|
  J. Baufreton and M. D. Bevan D2-like dopamine receptor-mediated modulation of activity-dependent plasticity at GABAergic synapses in the subthalamic nucleus J. Physiol., April 15, 2008; 586(8): 2121 - 2142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ramanathan, T. Tkatch, J. F. Atherton, C. J. Wilson, and M. D. Bevan D2-Like Dopamine Receptors Modulate SKCa Channel Function in Subthalamic Nucleus Neurons Through Inhibition of Cav2.2 Channels J Neurophysiol, February 1, 2008; 99(2): 442 - 459. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
TOP
ABSTRACT
INTRODUCTION
